EPISODE · Apr 25, 2026 · 6 MIN
A shift in temperature: The death of therapeutic hypothermia
from ALS Insights – Life Support Institute of Australia · host Life Support Institute of Australia
Is induced hypothermia dead? In this episode, we dive into the shifting paradigm of Advanced Life Support (ALS) post-resuscitation care. Following the TTM-2 trial and updated ILCOR/ANZCOR guidelines, the focus has shifted from deep therapeutic hypothermia (32–34°C) to strict fever prevention and targeted normothermia (36°C) for comatose post-cardiac arrest patients. We discuss the evidence, the dangers of over-cooling, and how to implement effective post-arrest care to improve neurological outcomes. Topics Covered:Why the "cool everything" approach failed.Targeted Temperature Management (TTM) vs. Therapeutic Hypothermia.Fever prevention as the new standard (≤37.5°C).Management of shivering and rewarming strategies.
What this episode covers
Is induced hypothermia dead? In this episode, we dive into the shifting paradigm of Advanced Life Support (ALS) post-resuscitation care. Following the TTM-2 trial and updated ILCOR/ANZCOR guidelines, the focus has shifted from deep therapeutic hypothermia (32–34°C) to strict fever prevention and targeted normothermia (36°C) for comatose post-cardiac arrest patients. We discuss the evidence, the dangers of over-cooling, and how to implement effective post-arrest care to improve neurological outcomes. Topics Covered:Why the "cool everything" approach failed.Targeted Temperature Management (TTM) vs. Therapeutic Hypothermia.Fever prevention as the new standard (≤37.5°C).Management of shivering and rewarming strategies.
NOW PLAYING
A shift in temperature: The death of therapeutic hypothermia
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m